Medicare Advantage Coding Practices Draw $56.5 Million False Claims Act Settlement

Key Takeaways

• Government Targets Diagnosis Generators: The settlement reflects growing federal scrutiny not only of Medicare Advantage insurers but also of the vendors, assessment companies, and individuals responsible for generating diagnosis data used in risk-adjustment payments.
• Allegedly Unsupported Diagnoses Drove Higher Payments: Prosecutors contend that Matrix and HealthFair reported diagnoses that lacked sufficient clinical support, resulting in inflated Medicare Advantage reimbursements from CMS.
• Individual Accountability Remains a Priority: HealthFair founder James Ekbatani agreed to pay $15 million as part of the resolution, underscoring the Justice Department's willingness to pursue executives alongside corporate entities.
• Risk Adjustment Continues to Be an Enforcement Hotspot: The case centers on Medicare Advantage's payment model, where diagnosis codes directly affect government reimbursements and remain a frequent focus of False Claims Act investigations.
• Vendors Face Increasing Regulatory Exposure: The settlement signals that organizations providing in-home assessments, screenings, and other clinical services can face substantial liability when diagnosis reporting practices fail to meet federal standards.

Deep Dive

Federal prosecutors announced that Matrix Medical Network, HealthFair, and HealthFair founder Shahriah “James” Ekbatani have agreed to pay a combined $56.5 million to resolve allegations that unsupported and invalid diagnoses were used to increase payments from the Medicare Advantage program. Matrix will pay $36.5 million, while HealthFair and Ekbatani agreed to pay $5 million and $15 million respectively.

The settlements arise from separate whistleblower lawsuits filed in New York and Texas. At their core is a question that has become increasingly familiar in Medicare Advantage enforcement actions: when does identifying medical conditions become manufacturing them?

According to the government, Matrix spent years reporting diagnoses generated during in-home assessments that frequently lacked sufficient support or failed to meet Medicare coding requirements. The company, based in Nashville, contracts with Medicare Advantage insurers to perform health assessments for beneficiaries in their homes.

The Justice Department alleges that from 2014 through 2019, Matrix reported diagnoses including atrial fibrillation, rheumatoid arthritis, chronic obstructive pulmonary disease, simple chronic bronchitis, proliferative diabetic retinopathy, drug-induced polyneuropathy, and rheumatoid polyneuropathy despite insufficient evidence to support them.

What drew the government's attention was not simply that the diagnoses were questionable. Prosecutors allege the conditions often disappeared the moment patients returned to the broader healthcare system. According to the settlement documents, many of the diagnoses were not identified by other healthcare providers during the same year as the home visit, nor in the two years before or after.

That pattern has become a recurring red flag in Medicare Advantage investigations. The program pays private insurers a fixed amount per enrollee, adjusted according to each patient's health status. Sicker patients generate higher payments. As a result, diagnosis codes carry financial significance far beyond the clinical record itself.

Federal officials allege that the diagnoses reported by Matrix ultimately helped Medicare Advantage organizations obtain risk-adjustment payments from the Centers for Medicare & Medicaid Services that they otherwise would not have received.

"Matrix advertised its ability to identify new diagnosis codes that would boost Medicare Advantage insurers' payments," U.S. Attorney Jay Clayton for the Southern District of New York said in announcing the settlement. According to Clayton, the company delivered diagnoses that frequently fell short of recognized clinical criteria while helping insurers secure higher reimbursements.

The allegations involving HealthFair were more striking still.

Before Matrix acquired the company in 2018, HealthFair operated mobile healthcare buses that traveled to communities and conducted health assessments for Medicare Advantage beneficiaries. Federal prosecutors allege that between 2015 and 2017, HealthFair providers reported serious medical conditions without documentation establishing that the conditions existed.

Among the diagnoses cited by the government were HIV/AIDS, metastatic cancer, and Myasthenia Gravis. Prosecutors also allege that some conditions were diagnosed solely on the basis of patient statements, historical claims data, medication records, or past medical history. In other cases, HealthFair providers allegedly diagnosed congestive heart failure and heart arrhythmias despite diagnostic testing that pointed in the opposite direction.

The government further contends that HealthFair submitted these diagnoses to its Medicare Advantage customers under the direction of founder James Ekbatani and that the diagnoses were frequently passed on to CMS for risk-adjusted reimbursement.

The GRC Report is your premier destination for the latest in governance, risk, and compliance news. As your reliable source for comprehensive coverage, we ensure you stay informed and ready to navigate the dynamic landscape of GRC. Beyond being a news source, the GRC Report represents a thriving community of professionals who, like you, are dedicated to GRC excellence. Explore our insightful articles and breaking news, and actively participate in the conversation to enhance your GRC journey.